Adherence to treatment recommendations from a referral center for myelodysplastic syndromes (MDS)

被引：0
|
作者：
Kasprzak, A. [1 ]
Kondakci, M. [1 ]
Nachtkamp, K. [1 ]
Kobbe, G. [1 ]
Schroeder, T. [1 ]
Kuendgen, A. [1 ]
Kaivers, J. [1 ]
Rautenberg, C. [1 ]
Haas, R. [1 ]
Gattermann, N. [1 ]
Germing, U. [1 ]
机构：
[1] Univ Hosp Dusseldorf, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V202
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [21] Myelodysplastic Syndromes (MDS) – News from ASH 2010
    T. Nösslinger
    M. Pfeilstöcker
    memo - Magazine of European Medical Oncology, 2011, 4 (2) : 110 - 112
  • [22] Myelodysplastic syndromes (MDS) - News from ASH 2010
    Noesslinger, T.
    Pfeilstoecker, M.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2011, 4 (02) : 110 - 112
  • [23] BIOSIMILAR EPOETIN ZETA FOR THE TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES (MDS)
    Pelizzari, A.
    Ferrero, D.
    Molteni, A.
    Allione, B.
    Mezzabotta, M.
    Clavio, M.
    Borlenghi, E.
    Rossi, G.
    Masiera, E.
    Santini, V.
    LEUKEMIA RESEARCH, 2015, 39 : S56 - S57
  • [24] Treatment and outcome of 23 paediatric patients with myelodysplastic syndromes (MDS)
    Polychronopoulou, S
    Panagiotou, JP
    Papadakis, V
    Parcharidou, A
    Psiachou, H
    Mavrou, A
    Haidas, S
    LEUKEMIA, 2000, 14 (05) : 969 - 969
  • [25] Myelodysplastic syndromes (MDS): An international practice and treatment survey.
    List, AF
    BLOOD, 2005, 106 (11) : 712A - 712A
  • [26] Combination of thalidomide and Enbrel for the treatment of patients with myelodysplastic syndromes (MDS).
    Raza, A
    Dutt, D
    Lisak, L
    Dean, L
    Fantroy, L
    Gezer, S
    Syed, E
    Goldberg, C
    Loew, J
    Hsu, WT
    Venugopal, P
    BLOOD, 2001, 98 (11) : 273B - 274B
  • [27] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) - update of the outpatient MDS registry
    Schmitz, S.
    Boettger, I
    Sauer, A.
    Buschmann, D.
    Germing, U.
    Severin, K.
    Steinmetz, H. T.
    ONKOLOGIE, 2013, 36 : 242 - 242
  • [28] Diagnosis, management and response criteria of iron overload in myelodysplastic syndromes (MDS): updated recommendations of the Austrian MDS platform
    Valent, Peter
    Stauder, Reinhard
    Theurl, Igor
    Geissler, Klaus
    Sliwa, Thamer
    Sperr, Wolfgang R.
    Bettelheim, Peter
    Sill, Heinz
    Pfeilstoecker, Michael
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (02) : 109 - 116
  • [29] Iron overload in myelodysplastic syndromes (MDS)
    Norbert Gattermann
    International Journal of Hematology, 2018, 107 : 55 - 63
  • [30] PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES (MDS)
    TRICOT, G
    VLIETINCK, R
    HENDRICKX, B
    VERWILGHEN, RL
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (02) : 362 - 362
12345